# XTL BIOPHARMACEUTICALS-ADR COM

XTL BIOPHARMACEUTICALS-ADR COM is a security (CUSIP 98386D406) tracked across SEC portfolio filings. 5 institutional managers reported $18K on Form 13F as of 2026-06-30.

## Summary

- Issuer: XTL BIOPHARMACEUTICALS-ADR
- Class: COM
- CUSIP: 98386D406
- 13F holders: 5
- 13F value: $18K
- 13F period: 2026-06-30
- N-PORT fund positions: 0

## Top institutional holders (Form 13F)

| Manager | Location | Value | Shares |
| --- | --- | --- | --- |
| [RHUMBLINE ADVISERS](https://search.stillhousedata.com/firm/107151) | BOSTON, MA | $14K | 5,987 |
| [GAMMA Investing LLC](https://search.stillhousedata.com/firm/312573) | FOSTER CITY, CA | $3K | 1,213 |
| Tower Research Capital LLC (TRC) | NEW YORK, NY | $588 | 244 |
| Noked Israel Ltd | Ramat Hasharon, L3 | $120 | 49,722 |
| MORGAN STANLEY | NEW YORK, NY | $24 | 10 |

## More

- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/security/98386D406.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.